대한방사선치료학회지 (The Journal of Korean Society for Radiation Therapy)

  • 제33권
  • /
  • Pages.35-46
  • /
  • 2021
  • /
  • 1598-8449(pISSN)
대한방사선치료학회 (Korean Society for Radiation Therapy)
권호 표지

폐암의 SABR(Stereotactic Ablative Radiotherapy)시 복부압박(Abdominal compression)과 CPAP(Continuous Positive Air Pressure)를 이용한 치료계획의 비교 및 평가

Comparison and evaluation of treatment plans using Abdominal compression and Continuous Positive Air Pressure for lung cancer SABR

  • 김대호 (서울대학교병원 방사선종양학과) ;
  • 손상준 (서울대학교병원 방사선종양학과) ;
  • 문준기 (서울대학교병원 방사선종양학과) ;
  • 박장필 (서울대학교병원 방사선종양학과) ;
  • 이제희 (서울대학교병원 방사선종양학과)
  • Kim, Dae Ho (Department of Radiation Oncology, Seoul National University Hospital) ;
  • Son, Sang Jun (Department of Radiation Oncology, Seoul National University Hospital) ;
  • Mun, Jun Ki (Department of Radiation Oncology, Seoul National University Hospital) ;
  • Park, Jang Pil (Department of Radiation Oncology, Seoul National University Hospital) ;
  • Lee, Je Hee (Department of Radiation Oncology, Seoul National University Hospital)
  • 발행 : 2021.12.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

목 적 : 폐암의 정위 절제 방사선 치료(Stereotactic Ablative Radiation Therapy, SABR)시 복부압박을 이용한 치료계획과 양압지속유지기(The Continuous Positive Air Pressure, CPAP)를 이용한 치료계획을 비교, 분석하여 방사선 치료 효과 향상에 기여하고자 한다. 대상 및 방법 : 본원의 폐의 SABR 환자 중 2명을 대상으로 복부 압박 고정 장치(the Body Pro-Lok, BPL)와 CPAP를 이용한 치료 계획을 수립하여, RTOG 0813에서 제안한 parameter들과 균질도(Homogeneity Index, HI), 일치도(Conformity Index, CI)를 통해 치료계획을 분석하였다. 또한 모든 4D CT에서 각 Phase별 계획용 표적 체적(Planning Target Volume, PTV) 중심의 X, Y, Z축 움직임을 분석하고, PTV와 손상위험장기(Organ At Risk, OAR)의 체적과 평균 선량을 구하여 비교하였다. 그리고 4개의 원뿔형빔 전산화단층촬영(Cone Beam Computed Tomography, CBCT)을 이용하여, PTV 중심점과 0°, 90°, 180°, 270° 중 세 방향에서의 흉강내 접점까지의 직선거리를 측정하고, 각 방향에서 평균거리 값과의 차이를 비교하였다. 결 과 : BPL과 CPAP를 사용하여 얻은 치료계획은 모두 RTOG의 권고값을 따랐으며, 균질도와 일치도에서도 큰 차이가 없었다. PTV 중심의 X축, Y축, Z축 움직임은 A 환자의 경우 BPL 사용시 0.49 cm, 0.37 cm, 1.66 cm, CPAP 사용시 0.16 cm, 0.12 cm, 0.19 cm을 보였고, B 환자의 경우 BPL 사용시 0.22 cm, 0.18 cm, 1.03 cm, CPAP 사용시 0.14 cm, 0.11 cm, 0.4 cm을 보였다. CPAP 사용시 BPL 사용시보다 A 환자의 경우 ITV가 46.27% 감소하였고 좌측 폐의 체적이 41.94% 증가하였으며, 평균선량은 심장에서 52.81% 감소하였다. B 환자의 경우 좌측 폐 106.89%, 우측 폐 87.32% 체적이 증가하였고, 평균선량은 위에서 44.30% 감소하였다. 각 방향의 직선거리 값과 평균거리 값과의 최대 차이는 A 환자의 경우 a방향에서 0.05 cm, b방향에서 0.05 cm, c방향에서 0.41 cm 났고, B 환자의 경우 d방향에서 0.19 cm, e방향에서 0.49 cm, f방향에서 0.06 cm 차이가 났다. 결 론 : CPAP 사용시 폐용적의 증가를 통해 표적 근처 OAR의 선량을 BPL 사용시보다 더 효과적으로 감소시킬 수 있으며, 호흡에 따른 종양의 움직임 제한에도 더 효과적으로 기여할 수 있다는 것을 확인하였다. 추후 CPAP의 다양한 부위 적용과 다른 치료기와의 결합을 통해 방사선 치료 효과를 개선시킬 수 있을 것으로 사료된다.

Purpose : By comparing and analyzing treatment plans using abdominal compression and The Continuous Positive Air Pressure(CPAP) during SABR of lung cancer, we try to contribute to the improvement of radiotherapy effect. Materials & Methods : In two of the lung SABR patients(A, B patient), we developed a SABR plan using abdominal compression device(the Body Pro-Lok, BPL) and CPAP and analyze the treatment plan through homogeneity, conformity and the parameters proposed in RTOG 0813. Furthermore, for each phase, the X, Y, and Z axis movements centered on PTV are analyzed in all 4D CTs and compared by obtaining the volume and average dose of PTV and OAR. Four cone beam computed tomography(CBCT) were used to measure the directions from the center of the PTV to the intrathoracic contacts in three directions out of 0°, 90°, 180° and 270°, and compare the differences from the average distance values in each direction. Result : Both treatment plans obtained using BPL and CPAP followed recommendations from RTOG, and there was no significant difference in homogeneity and conformity. The X-axis, Y-axis, and Z-axis movements centered on PTV in patient A were 0.49 cm, 0.37 cm, 1.66 cm with BPL and 0.16 cm, 0.12 cm, and 0.19 cm with CPAP, in patient B were 0.22 cm, 0.18 cm, 1.03 cm with BPL and 0.14 cm, 0.11 cm, and 0.4 cm with CPAP. In A patient, when using CPAP compared to BPL, ITV decreased by 46.27% and left lung volume increased by 41.94%, and average dose decreased by 52.81% in the heart. In B patient, volume increased by 106.89% in the left lung and 87.32% in the right lung, with an average dose decreased by 44.30% in the stomach. The maximum difference of A patient between the straight distance value and the mean distance value in each direction was 0.05 cm in the a-direction, 0.05 cm in the b-direction, and 0.41 cm in the c-direction. In B patient, there was a difference of 0.19 cm in the d-direction, 0.49 cm in the e-direction, and 0.06 cm in the f-direction. Conclusion : We confirm that increased lung volume with CPAP can reduce doses of OAR near the target more effectively than with BPL, and also contribute more effectively to restriction of tumor movement with respiration. It is considered that radiation therapy effects can be improved through the application of various sites of CPAP and the combination with CPAP and other treatment machines.

키워드

참고문헌

  1. Vansteenkiste J, De Ruysscher D, Eberhardt WE et al (2013) Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 24(Suppl 6):vi89-vi98
  2. Robert D, Timmerman MD, Brain D, et al: Stereotactic Body Radiation Therapy in Multiple Organ Sites. Journal of Clinical Oncology 25:947-52 (2007) https://doi.org/10.1200/JCO.2006.09.7469
  3. Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010; 303: 1070±1076. https://doi.org/10.1001/jama.2010.261 PMID: 20233825
  4. Ricardi U, Badellino S, Filippi AR. Stereotactic radiotherapy for early stage non-small cell lung cancer. Radiat Oncol J. 2015; 33: 57±65. https://doi.org/10.3857/roj.2015.33.2.57 PMID: 26157674
  5. Verstegen NE, Lagerwaard FJ, Hashemi SMet al (2015) Patterns of disease recurrence after SABR for early stage non-small-cell lung cancer: optimizing follow-up schedules for salvage therapy. J Thorac Oncol 10:1195--1200 https://doi.org/10.1097/JTO.0000000000000576
  6. Chi A, Nguyen NP, Komaki R. The potential role of respiratory motion management and image guidance in the reduction of severe toxicities following stereotactic ablative radiation therapy for patients with centrally located early stage non-small cell lung cancer or lung metastases. Front Oncol 2014;4:151. https://doi.org/10.3389/fonc.2014.00151
  7. Keall PJ, Mageras GS, Balter JM, et al. The management of respiratory motion in radiation oncology report of AAPM task group 76. Med Phys 2006;33:3874-3900. https://doi.org/10.1118/1.2349696
  8. Goldstein JD, Lawrence YR, Appel S et al (2015) Continuous positive airway pressure for motion management in stereotactic body radiation therapy to the lung: a controlled pilot study. Int J Radiat Oncol Biol Phys 93:391--399 https://doi.org/10.1016/j.ijrobp.2015.06.011
  9. Strollo PJ Jr., Sanders MH, Atwood CW. Positive pressure therapy. Clin Chest Med 1998;19:55-68. https://doi.org/10.1016/S0272-5231(05)70431-7
  10. Rappard S, Hickey J. Just the berries. Use of CPAP and BIPAP in acute respiratory failure. Can Fam Physician 2001;47:269-270.
  11. O''Donoghue FJ, Catcheside PG, Jordan AS, et al. Effect of CPAP on intrinsic PEEP, inspiratory effort, and lung volume in severe stable COPD. Thorax 2002;57:533-539. https://doi.org/10.1136/thorax.57.6.533
  12. ROTG. Seamless phase I/II study of stereotactic lung radiotherapy (SBRT) for early stage, centrally located, non-small cell lung cancer (NSCLC) in medically inoperable patients. RTOG 0813. Philadelphia, PA: ROTG; 2014.
  13. Rebecca Van Gelder, BAppSci,, Shelley Wong, BAppSci,, Andrew Le, BAppSci et al. Experience with an abdominal compression band for radiotherapy of upper abdominal tumours. J Med Radiat Sci. 2018 Mar; 65(1): 48-54. https://doi.org/10.1002/jmrs.254
  14. Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013; 368:987-998. https://doi.org/10.1056/NEJMoa1209825
  15. Chargari C, Riet F, Mazevet M, et al. Complications of thoracic radiotherapy. Presse Med 2013;42:e342-e351. https://doi.org/10.1016/j.lpm.2013.06.012
  16. Beukema JC, van Luijk P, Widder J, et al. Is cardiac toxicity a relevant issue in the radiation treatment of esophageal cancer? Radiother Oncol 2015;114:85-90. https://doi.org/10.1016/j.radonc.2014.11.037
  17. Thompson R, Giuliani M, Yap ML, et al. Stereotactic body radiotherapy in patients with previous pneumonectomy: Safety and efficacy. J Thorac Oncol 2014;9:843-847. https://doi.org/10.1097/jto.0000000000000159
  18. Trovo M, Minatel E, Durofil E, et al. Stereotactic body radiation therapy for re-irradiation of persistent or recurrent non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2014;88:1114-1119. https://doi.org/10.1016/j.ijrobp.2014.01.012